Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$551M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$397M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$389M |
| 4 |
AABA
Altaba Inc
AABA
|
+$359M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$333M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$516M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$352M |
| 3 |
Lowe's Companies
LOW
|
+$252M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$219M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.34% |
| 2 | Financials | 4.89% |
| 3 | Consumer Discretionary | 3.06% |
| 4 | Healthcare | 3% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
PUT
Ionis Pharmaceuticals
IONS
$9.2B
| $1.51M | ﹤0.01% |
34,200
-2,300
| -6% | -$117K |
|
|
ICPT
2827
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.51M | ﹤0.01% |
24,500
+1,100
| +5% | +$66.3K |
|
2828
Perrigo
PRGO
$1.78B
| $1.51M | ﹤0.01% |
18,060
-59,330
| -77% | -$5.18M |
|
|
CHU
2829
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $1.5M | ﹤0.01% |
117,095
+10,328
| +10% | +$138K |
|
2830
PUT
Sabre
SABR
$818M
| $1.5M | ﹤0.01% |
+70,000
| New | +$1.5M |
|
2831
Tanger
SKT
$4.51B
| $1.5M | ﹤0.01% |
68,084
-5,563
| -8% | -$130K |
|
2832
PUT
United Natural Foods
UNFI
$2.86B
| $1.5M | ﹤0.01% |
34,900
-19,200
| -35% | -$868K |
|
|
FNSR
2833
PUT
DELISTED
Finisar Corp
FNSR
| $1.5M | ﹤0.01% |
94,800
-37,600
| -28% | -$710K |
|
|
UN
2834
CALL
DELISTED
Unilever NV New York Registry Shares
UN
| $1.5M | ﹤0.01% |
26,500
+10,600
| +67% | +$583K |
|
2835
PUT
RH
RH
$3.67B
| $1.5M | ﹤0.01% |
15,700
-31,500
| -67% | -$2.79M |
|
2836
CALL
Motorola Solutions
MSI
$77.9B
| $1.5M | ﹤0.01% |
14,200
-16,900
| -54% | -$1.73M |
|
|
BFIT
2837
DELISTED
Global X Funds Global X Health & Wellness ETF
BFIT
| $1.49M | ﹤0.01% |
85,000
| – | – |
|
2838
First Majestic Silver
AG
$8.92B
| $1.49M | ﹤0.01% |
243,372
-159,158
| -40% | -$978K |
|
|
MDC
2839
CALL
DELISTED
M.D.C. Holdings, Inc.
MDC
| $1.49M | ﹤0.01% |
62,146
+54,242
| +686% | +$1.43M |
|
2840
CAE Inc. Common Shares
CAE
$8.72B
| $1.49M | ﹤0.01% |
79,951
-1,284
| -2% | -$23.6K |
|
2841
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.82B
| $1.49M | ﹤0.01% |
52,674
-5,420
| -9% | -$159K |
|
|
HOLX
2842
PUT
DELISTED
Hologic
HOLX
| $1.49M | ﹤0.01% |
39,800
+29,700
| +294% | +$1.2M |
|
|
CSR
2843
Centerspace
CSR
$949M
| $1.48M | ﹤0.01% |
28,604
-4,652
| -14% | -$243K |
|
2844
Boston Beer
SAM
$1.92B
| $1.48M | ﹤0.01% |
7,842
+4,950
| +171% | +$910K |
|
2845
Community Health Systems
CYH
$426M
| $1.48M | ﹤0.01% |
373,464
+173,988
| +87% | +$873K |
|
2846
Celanese
CE
$4.89B
| $1.48M | ﹤0.01% |
14,739
-11,752
| -44% | -$1.24M |
|
2847
Cabot Corp
CBT
$4.48B
| $1.48M | ﹤0.01% |
26,491
+14,589
| +123% | +$921K |
|
2848
Coherus Oncology
CHRS
$210M
| $1.48M | ﹤0.01% |
133,534
+95,203
| +248% | +$1.04M |
|
2849
Ironwood Pharmaceuticals
IRWD
$706M
| $1.48M | ﹤0.01% |
114,186
-72,095
| -39% | -$898K |
|
2850
CALL
Reliance Steel & Aluminium
RS
$21.6B
| $1.48M | ﹤0.01% |
17,200
-11,200
| -39% | -$1M |
|
Similar funds
Citigroup's Q1 2018 Portfolio in Review
As of Q1 2018, Citigroup held 7,881 positions worth $121B, down 2.7% from $125B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citigroup's Q1 2018 filing shows 268 new, 3,114 increased, 3,575 reduced and 287 closed positions. Its largest new stake was Nutrien: 402,771 shares worth $19M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 4.2% a quarter earlier, followed by Financials and Consumer Discretionary.
- Citigroup's largest Q1 2018 buy was Nutrien: 402,771 shares worth $19M.
- Citigroup added most to Invesco QQQ Trust in Q1 2018, an estimated $551M increase.
- Citigroup's biggest Q1 2018 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
- Citigroup fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $82.7M.
- Citigroup's ten largest holdings make up 28% of its $121B portfolio in Q1 2018.
- Citigroup opened 268 new positions and closed 287 in Q1 2018.
- Citigroup's portfolio value fell 2.7% quarter-over-quarter to $121B.
Based on Citigroup's 13F filing for Q1 2018, filed 11 May 2018.